The role of programmed death ligand 1 pathway in persistent biomaterial-associated infections

被引:0
|
作者
Agnieszka Magryś
Jolanta Paluch-Oleś
Agnieszka Bogut
Michał Kiełbus
Dorota Plewik
Maria Kozioł-Montewka
机构
[1] Medical University of Lublin,Chair and Department of Medical Microbiology
[2] Medical University of Lublin,Chair and Department of Biochemistry and Molecular Biology
[3] Pope John Paul II State School of Higher Education in Biala Podlaska,Research Centre for Innovation
来源
Journal of Microbiology | 2015年 / 53卷
关键词
PD-L1; small colony variants; biomaterial-associated infections;
D O I
暂无
中图分类号
学科分类号
摘要
Staphylococcus epidermidis is commonly involved in biomaterial-associated infections. Bacterial small colony variants (SCV) seem to be well adapted to persist intracellularly in professional phagocytes evading the host immune response. We studied the expression of PD-L1/L2 on macrophages infected with clinical isolates of S. epidermidis SCV and their parent wild type (WT) strains. The cytokine pattern which is triggered by the examined strains was also analysed. In the study, we infected macrophages with S. epidermidis WT and SCV strains. Persistence and release from macrophages were monitored via lysostaphin protection assays. Moreover, the effect of IFN-γ pre-treatment on bacterial internalisation was investigated. Expression of PD-L1/L2 molecules was analysed with the use of FACS. Inflammatory reaction was measured by IL-10, TNF-α ELISAs, and transcriptional induction of TNF-α. Our study revealed that clinical SCV isolates were able to persist and survive in macrophages for at least 3 days with a low cytotoxic effect and a reduced proinflammatory response as compared to WT strains. Bacteria upregulated PD-L1/L2 expression on macrophages as compared to non-stimulated cells. The results demonstrated that the ability of S. epidermidis SCVs to induce elevated levels of anti-inflammatory cytokine, IL-10, and reduced transcriptional induction of TNF-α, together with expression of PD-L1 on macrophages and the ability to persist intracellularly without damaging the host cell could be the key factor contributing to chronicity of SCV infections.
引用
收藏
页码:544 / 552
页数:8
相关论文
共 50 条
  • [31] Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
    Xiaoyun Li
    Qin Zeng
    Fengjiao Xu
    Yuying Jiang
    Zhongmei Jiang
    Molecular Diversity, 2023, 27 : 1935 - 1955
  • [32] Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
    Katherine Chang
    Catherine Svabek
    Cristina Vazquez-Guillamet
    Bryan Sato
    David Rasche
    Strother Wilson
    Paul Robbins
    Nancy Ulbrandt
    JoAnn Suzich
    Jonathan Green
    Andriani C Patera
    Wade Blair
    Subramaniam Krishnan
    Richard Hotchkiss
    Critical Care, 18
  • [33] Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
    Chang, Katherine
    Svabek, Catherine
    Vazquez-Guillamet, Cristina
    Sato, Bryan
    Rasche, David
    Wilson, Strother
    Robbins, Paul
    Ulbrandt, Nancy
    Suzich, JoAnn
    Green, Jonathan
    Patera, Andriani C.
    Blair, Wade
    Krishnan, Subramaniam
    Hotchkiss, Richard
    CRITICAL CARE, 2014, 18 (01):
  • [34] Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
    Li, Xiaoyun
    Zeng, Qin
    Xu, Fengjiao
    Jiang, Yuying
    Jiang, Zhongmei
    MOLECULAR DIVERSITY, 2023, 27 (04) : 1935 - 1955
  • [35] Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
    Nomi, Takeo
    Sho, Masayuki
    Akahori, Takahiro
    Hamada, Kaoru
    Kubo, Atsushi
    Kanehiro, Hiromichi
    Nakamura, Shinji
    Enomoto, Koji
    Yagita, Hideo
    Azuma, Miyuki
    Nakajima, Yoshiyuki
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2151 - 2157
  • [36] Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma
    Zhitao Dong
    Boyi Liao
    Weifeng Shen
    Chengjun Sui
    Jiamei Yang
    Digestive Diseases and Sciences, 2020, 65 : 480 - 488
  • [37] The Prognostic Role of Programmed Death-Ligand 1 in Nasopharyngeal Carcinoma
    Wotman, Michael
    Herman, Saori W.
    Costantino, Peter
    Tham, Tristan
    LARYNGOSCOPE, 2020, 130 (11): : 2598 - 2606
  • [38] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    慢性疾病与转化医学(英文), 2019, 5 (03) : 170 - 177
  • [39] EVALUATION OF 'PROGRAMMED DEATH-1' / 'PROGRAMMED DEATH LIGAND 1 AND 2' PATHWAY IN TUMOR SAMPLES OF SEMINOMA AND NON-SEMINOMA, AND ITS PROGNOSTIC ROLE IN TESTICULAR CANCERS
    Garayev, Asgar
    Bozkurtlar, Emine
    Filinte, Deniz
    Cam, Haydar Kamil
    Simsek, Ferruh
    Tinay, Ilker
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1082 - E1083
  • [40] Targeting Programmed Death 1/Programmed Death Ligand 1 in Lymphoma: A Game Changer
    Younes, Anas
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (02) : 107 - +